What is erythromegalia (also known as erythromelalgia)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Erythromelalgia is a rare disorder characterized by episodic, burning pain associated with erythema and warmth of the extremities, particularly the feet and hands, which can significantly impact quality of life, increase morbidity and mortality, and is essential to diagnose and manage effectively to avoid severe complications 1.

Definition and Characteristics

Erythromelalgia (EM) is a rare neurovascular disorder that causes episodes of burning pain, redness, and increased skin temperature primarily affecting the extremities. It occurs when blood vessels periodically dilate, causing increased blood flow and inflammation in the affected areas. Episodes are typically triggered by heat exposure, exercise, or pressure on the affected limbs, and can be relieved by cooling the area.

Diagnosis and Classification

Erythromelalgia can be primary (genetic or idiopathic) or secondary to underlying conditions like blood disorders, autoimmune diseases, or medication side effects. The terms primary EM and secondary EM have been advocated, but the use of these terms varies and can be confusing. Conventionally, secondary EM is used for EM with an identifiable underlying cause; primary EM is used for EM with no identifiable underlying cause (idiopathic EM) 1.

Treatment and Management

Treatment of erythromelalgia focuses on avoiding triggers, lifestyle modifications, and pharmacologic treatments, including topical and systemic medications, with a step-wise approach starting with first-line therapy, followed by second-line and third-line therapy if necessary 1.

  • First-line therapy includes topical therapy and aspirin 325 mg orally daily for a trial of 1 month.
  • Second-line therapy includes systemic therapy, such as gabapentin, pregabalin, or amitriptyline, for a trial of 3-4 months.
  • Third-line therapy includes referral to a pain rehabilitation center. Patients should avoid heat exposure, wear loose-fitting clothes and shoes, and elevate affected limbs during episodes. Cooling the affected areas safely, such as ice and water immersion of extremities limited to 10 minutes at a time and 4 times daily, can also help alleviate symptoms. Healthcare may temporarily help alleviate symptoms during EM flares 1.

From the Research

Definition and Characteristics of Erythromelalgia

  • Erythromelalgia is a rare clinical condition characterized by intense burning pain, pronounced erythema, and increased skin temperature 2, 3, 4, 5, 6
  • It can be divided into primary and secondary forms, with primary erythromelalgia beginning spontaneously at any age and secondary erythromelalgia associated with various medical conditions 2, 3, 5

Symptoms and Diagnosis

  • Symptoms of erythromelalgia include severe pain, redness, and hotness in extremities, often triggered by exposure to warmth, pressure, or exercise 2, 3, 5
  • Diagnosis is based on medical history and clinical findings, with no diagnostic tests available 2, 3

Treatment and Management

  • Various medications, including aspirin, propranolol, and anticonvulsants, have been used to treat erythromelalgia, with some patients experiencing relief 2, 5
  • Procedural interventions, such as epidural infusion and sympathetic ganglion block, have also been explored as treatment options, although evidence is limited 4

Associated Conditions and Complications

  • Erythromelalgia has been linked to various myeloproliferative disorders, including polycythemia vera and essential thrombocythemia 5
  • Symptoms of erythromelalgia can precede the onset of a myeloproliferative disease, highlighting the importance of monitoring patients with erythromelalgia for underlying conditions 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Erythromelalgia.

Acta dermatovenerologica Croatica : ADC, 2004

Research

Erythromelalgia: a rare microvascular disease.

Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing, 2010

Research

Procedural interventions for erythromelalgia: A narrative review.

Vascular medicine (London, England), 2024

Research

Erythromelalgia and myeloproliferative disorders.

Archives of internal medicine, 1989

Research

Erythromelalgia involving the face.

Dermatology online journal, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.